A detailed history of Captrust Financial Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Captrust Financial Advisors holds 214,539 shares of LLY stock, worth $171 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
214,539
Previous 262,268 18.2%
Holding current value
$171 Million
Previous $237 Million 19.96%
% of portfolio
0.58%
Previous 0.77%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $36.9 Million - $45.8 Million
-47,729 Reduced 18.2%
214,539 $190 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $244 Million - $306 Million
-336,566 Reduced 56.2%
262,268 $237 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $174 Million - $232 Million
293,050 Added 95.84%
598,834 $466 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.27 Million - $1.5 Million
-2,426 Reduced 0.79%
305,784 $178 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $2.48 Million - $3.42 Million
5,714 Added 1.89%
308,210 $166 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $23.8 Million - $31.9 Million
-67,925 Reduced 18.34%
302,496 $142 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $62,126 - $72,964
-200 Reduced 0.05%
370,421 $127 Million
Q4 2022

Feb 15, 2023

BUY
$321.55 - $374.67 $7.25 Million - $8.45 Million
22,554 Added 6.48%
370,621 $136 Million
Q3 2022

Nov 16, 2022

SELL
$296.48 - $337.87 $2.29 Million - $2.61 Million
-7,717 Reduced 2.17%
348,067 $113 Million
Q2 2022

Aug 23, 2022

SELL
$278.73 - $327.27 $3.45 Million - $4.05 Million
-12,384 Reduced 3.36%
355,784 $115 Million
Q2 2022

Aug 16, 2022

BUY
$278.73 - $327.27 $15.2 Million - $17.8 Million
54,400 Added 17.34%
368,168 $119 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $7.93 Million - $9.86 Million
33,807 Added 12.08%
313,768 $89.9 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $2.62 Million - $3.25 Million
11,642 Added 4.34%
279,961 $77.3 Million
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $7.69 Million - $9.47 Million
34,709 Added 14.86%
268,319 $62 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $28.4 Million - $36.7 Million
157,187 Added 205.68%
233,610 $53.6 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $1 Million - $1.3 Million
6,102 Added 8.68%
76,423 $14.3 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $8.58 Million - $11.3 Million
-65,734 Reduced 48.31%
70,321 $11.9 Million
Q3 2020

Nov 17, 2020

BUY
$146.22 - $169.13 $334,990 - $387,476
2,291 Added 1.71%
136,055 $19.6 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $2.71 Million - $3.27 Million
19,897 Added 17.47%
133,764 $21.8 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $3.22 Million - $3.98 Million
27,040 Added 31.14%
113,867 $15.5 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $6.76 Million - $8.37 Million
63,187 Added 267.29%
86,827 $11.5 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $34,706 - $37,752
-325 Reduced 1.36%
23,640 $2.64 Million
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $187,899 - $219,326
-1,696 Reduced 6.61%
23,965 $2.66 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $449,024 - $528,534
4,034 Added 18.65%
25,661 $3.33 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $9,213 - $10,321
87 Added 0.4%
21,627 $2.5 Million
Q3 2018

Nov 15, 2018

BUY
$85.86 - $107.31 $1.06 Million - $1.33 Million
12,360 Added 134.64%
21,540 $2.31 Million
Q2 2018

Aug 13, 2018

BUY
$75.7 - $86.88 $513,548 - $589,393
6,784 Added 283.14%
9,180 $783,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $23,376 - $27,594
-315 Reduced 11.62%
2,396 $181,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $189,363 - $203,113
2,311 Added 577.75%
2,711 $229,000
Q3 2017

Feb 16, 2018

BUY
$77.07 - $85.54 $30,827 - $34,216
400
400 $30,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.